JPRN-UMIN000044132RecruitingPhase 2
Study on the safety of modified MCT ketogenic diet and standard therapy combination therapy for colorectal cancer patients - Study on MCT ketogenic diet for colorectal cancer patients
Toho University Omori Medical Center, Department of Nutrition Therapy Center0 sites50 target enrollmentStarted: May 8, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Weight loss of 5% or more has been observed in the last 3 months. 2. Highly advanced example (Exclusion example) When there is liver metastasis, deterioration of liver function, jaundice, and ascites. (Exclusion example) When there is lung metastasis and there are clinical symptoms such as pleural effusion and respiratory distress. However, bone metastases and brain metastases are not excluded. 3. If you have a history of ileus or peritoneal dissemination.
Investigators
Similar Trials
Recruiting
Phase 2
Study on the safety of modified MCT ketogenic diet and standard therapy combination therapy for breast cancer patientsBreast cancerJPRN-UMIN000044125Toho University Omori Medical Center, Department of Nutrition Therapy Center50
Not yet recruiting
Phase 2
Effects of ketogenic diet in patients with endometriosisEndometriosis.Endometriosis of uterusN80.0IRCT20131125015536N15Tehran University of Medical Sciences50
Recruiting
Phase 2
Safety and feasibility of the ketogenic diet in therapy resistand paediatric recurrent or progressive pontine glioma, a pilot studyNL-OMON33175Erasmus MC, Universitair Medisch Centrum Rotterdam10
Recruiting
Phase 1
Investigating the effect of a ketogenic diet on the treatment process of patients with non-metastatic rectal cancer requiring chemoradiotherapyRectal cancer, ketogenic diet.IRCT20240410061465N1Oroumia University of Medical Sciences50
Completed
Phase 1
Study on the safety and efficacy of the ketogenic diets for stage IV advanced and recurrent cancer patients.JPRN-UMIN000039925Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation Department of Surgery30